Indo US Bio-Tech passes all five AGM resolutions including auditor appointment
- Indo US Bio-Tech Limited passed all five resolutions at its 22nd AGM held on September 30, 2026.
- Resolutions included adoption of FY26 financials, auditor appointment, and borrowing limit approval.
- Total votes polled were 1,48,41,548, with 98.52% in favour across all items.
- Promoter group held 1,36,93,643 shares, while public non-institutions voted 11,47,905 shares.
- No institutional shareholder votes were recorded during the remote e-voting process.

*this image is generated using AI for illustrative purposes only.
Indo US Bio-Tech Limited concluded its 22nd Annual General Meeting on September 30, 2026, with all five proposed resolutions passing by requisite majority. The meeting was conducted via video conferencing.
The company reported that 17 shareholders attended the virtual meeting. This included six members from the promoter and promoter group and eleven public shareholders. Voting results were scrutinized by Amrish Gandhi & Associates, Company Secretaries.
Resolution Outcomes
The shareholders approved the adoption of audited financial statements for FY26, the re-appointment of a director retiring by rotation, and the appointment of new statutory auditors. Additionally, a special resolution regarding borrowing limits and an ordinary resolution approving related party transactions were passed.
| Resolution | Type | Votes in Favour (%) | Votes Against (%) | Status |
|---|---|---|---|---|
| Adoption of Audited Financials | Ordinary | 98.52 | 1.48 | Passed |
| Re-appointment of Director | Ordinary | 98.52 | 1.48 | Passed |
| Appointment of Statutory Auditor | Ordinary | 98.52 | 1.48 | Passed |
| Borrowing Limit Approval | Special | 98.52 | 1.48 | Passed |
| Related Party Transaction | Ordinary | 98.52 | 1.48 | Passed |
Voting Participation Details
Remote e-voting was conducted between September 27 and September 29, 2026. The total number of votes polled across all resolutions stood at 1,48,41,548. Promoters and promoter group members cast 1,36,93,643 votes, representing 100% of their holding. Public non-institutional shareholders polled 11,47,905 votes, which constituted 18.05% of their total holdings.
Notably, no votes were recorded from public institutional shareholders. For the resolution concerning the re-appointment of Mrs. Priyanka Samarth Patel, promoter votes were declared invalid due to interest in the matter, yet the resolution still passed with a substantial majority of valid votes.
Historical Stock Returns for Indo Us Bio-Tech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.88% | -1.73% | -5.14% | -21.85% | -42.15% | -73.77% |
How will the newly approved borrowing limits impact Indo US Bio-Tech's capital expenditure plans and debt-to-equity ratio in the upcoming fiscal year?
What specific strategic initiatives or expansion projects are driving the need for increased borrowing capacity and related party transactions?
Given the low public institutional participation, what steps is the company taking to enhance governance transparency to attract long-term institutional investors?

































